---
title: diagnostic evaluation of essential thrombocythemia (ET)
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[essential thrombocythemia (ET)]]

# diagnostic evaluation of essential thrombocythemia (ET) #ðŸš§ æ–½å·¥ä¸­

## diagnostic evaluation of essential thrombocythemia (ET)

â€¢ Peripheral smear: large hypogranular platelets

â€¢ BM bx: megakaryocytic hyperplasia; âŠ– Phil chr; rarely minor reticulin fibrosis; nl Fe; if atypical megakaryoctyes or â†‘ reticulin, consider pre-PMF (Rx same as ET, but â†‘ risk MF)

â€¢ Mutations:Â **_JAK2_Â V617F**Â in ~50%;Â **_CALR_**Â in ~45%;Â **_MPL_**Â in 5â€“10%; triple negative <5%

â€¢ Patients should not meet WHO criteria for diagnosis of CML, PV, PMF, or MDS

â€¢ Check vWF in pts w/ plt>1,000,000 and hold ASA (vide infra) if acquired vWD

![](opeb://ea31ded4eb7f3d96eaf79a9bf60fa8fc/images/00081.jpeg)

